In today’s evolving healthcare environment, clinicians are dealing with a global challenge of multidrug-resistant organisms (MDROs) and adverse drug events while trying to reduce health care costs and improve patient care. According to the CDC, antibiotic-resistant infections affect at least 2 million people in the U.S. annually and result in > 23,000 deaths.1 As a way to combat this growing concern, antimicrobial stewardship programs have been designed to optimize the management of infectious diseases. However, this cannot be done without the collaboration among several teams within a healthcare system.
This program will provide an overview of the essential role the hospital laboratory plays in the conduct of institutional antibiotic stewardship programs. The program will focus on issues currently impacting the hospital laboratories, including rapid diagnostic testing, antimicrobial susceptibility reporting, and the use of select biomarkers in the management of infectious diseases.
1 The Importance of an Antimicrobial Stewardship Program, Federal Practitioner; September 2015;32(9):20-24, Roula Baroudi, MD Marquetta Flaugher, PhD, ARNP Eddie Grace, PharmD Danny Zakria